Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capsimax for appetite and energy intake in obesity
NCT04874701Phase 4Completed
- Sponsor
- Université Laval
- Start
- Jan 2018
- Primary completion
- Jul 2019
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial (2 arms), sponsored by Université Laval. Primary endpoints: Change from Baseline in appetite sensations at 12 weeks, Change from Baseline in energy intake at 12 weeks and 5 more. Started Jan 2018; status: completed.
Beyond the preview
Go deeper on NCT04874701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04874701.